Health Trials

Clinical trials

8

Search and review clinical trials. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

BL1107 Response and Intensity Guided Dosing for Hyperemia Resolution Trial

Trial RX01-BL1107-1202 is designed to identify the lowest effective concentration of BL1107 required for complete resolution of conjunctival hyperemia in participants with DED. Participants will be masked to concentration of BL1107 received.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Aug 21, 2026
Eligibility criteria

Documented diagnosis of dry eye disease [+1]

Any active ocular disease [+1]

Read more
Status: Recruiting

A Study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Trial Participants

Single center, double-masked study of BL1332 on Capsaicin-Induced Ocular Pain in Healthy Subjects

Participants needed: 28
Trial details
Phase: Phase 1Age: 18-65Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jul 21, 2026Locations: 1
Eligibility criteria

Male or female ≥ 18 to ≤ 65 years of age. [+2]

Women of childbearing potential or non-vasectomized males with partners of child... [+2]

Read more
Status: Not yet recruiting

A Study to Evaluate the Use of Topical Ocular BL1332 for the Management of Postoperative Ocular Pain Following Photorefractive Keratectomy

This is a multicenter, double-masked study to evaluate the use of Topical Ocular BL1332 for the management of post-operative pain after Photorefractive Keratectomy (PRK) surgery.

Participants needed: 123
Trial details
Phase: Phase 2Age: 18-58Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Feb 17, 2026
Eligibility criteria

Male or female 18 to 58 years of age, inclusive. [+3]

Women of childbearing potential or non-vasectomized males with partners of child... [+1]

Read more
Status: Not yet recruiting

A Study to Investigate the Safety and Effectiveness of the Technolas® TENEO 317 Model 2 Excimer Laser for Laser In Situ Keratomileusis (LASIK) Surgery to Treat Myopia or Myopic Astigmatism

This will be a multicenter, prospective, open label, non-randomized, single arm study evaluating the safety and effectiveness of the Technolas® TENEO 317 Model 2 (version 1.28 US software) Excimer Laser when used in LASIK surgery to treat myopia or myopic astigmatism. One or both eyes of a subject may be treated so long as both eyes meet all inclusion/exclusion requirements.

Participants needed: 32
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jan 30, 2026
Eligibility criteria

Are 22 years of age or older. [+13]

Subjects for whom the combination of their baseline corneal thickness and the pl... [+22]

Read more
Status: Recruiting

IC-8 Apthera IOL New Enrollment Post Approval Study

The purpose of this study is to verify the post-market safety of the IC-8 Apthera IOL after the treatment of posterior capsular opacification (PCO), an expected complication related to IC-8 Apthera IOL implantation.

Participants needed: 435
Trial details
Age: 22+Biological sex: AllType: ObservationalSponsor: Bausch & Lomb IncorporatedUpdated: Jan 12, 2026Locations: 14
Eligibility criteria

22 years of age or older, any race and any gender; [+6]

Pharmacologically dilated pupil size less than 7.0 mm in the IC-8 Apthera IOL ey... [+11]

Read more
Status: Not yet recruiting

Revive Toric RWE Study

This is a post-market observational clinical investigation. The objective of this observational study is to evaluate the visual performance and HCP satisfaction of REVIVE samfilcon B custom toric contact lenses.

Participants needed: 30
Trial details
Age: 18+Biological sex: AllType: ObservationalSponsor: Bausch & Lomb IncorporatedUpdated: Nov 28, 2025Locations: 3
Eligibility criteria

Be 18 years or older on the date the ICF is signed [+8]

Is participating in another research study [+4]

Read more
Status: Not yet recruiting

Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia With or Without Astigmatism by Transepithelial Photorefractive Keratectomy

A Study to Investigate the Effectiveness and Safety of the TENEO 317 Model 2 Excimer Laser to Treat Myopia with or without Astigmatism by Transepithelial Photorefractive Keratectomy

Participants needed: 140
Trial details
Age: 22+Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jun 15, 2025
Eligibility criteria

22 years of age or older at the time of the pre-operative examination. [+11]

Acute or chronic disease or illness that would increase operative risk or confou... [+14]

Read more
Status: Recruiting

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

A Study to Evaluate the Safety and Efficacy of the Bausch + Lomb Myopia Control Lens for the Correction of Myopic Ametropia and Slowing the Progression of Myopia in Children

Participants needed: 418
Trial details
Age: 8-12Biological sex: AllType: InterventionalSponsor: Bausch & Lomb IncorporatedUpdated: Jun 15, 2025Locations: 11
Eligibility criteria

Male or female aged 8 to 12 years plus 11 months old on the date the Informed As... [+8]

Subject has previously worn, or currently wears rigid gas permeable contact lens... [+16]

Read more